Perceived support for medical cannabis use among approved medical cannabis users in Canada

Leos‐Toro, Cesar; Shiplo, Samantha; Hammond, David

doi:10.1111/dar.12823

Cited by 31 publications

(21 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[35][36][37][38] Another reason for the increase in cannabis use is the changes in public perception regarding cannabis. [39][40][41] Currently, the majority of American people support cannabis legalization and a record high support has been documented in recent years. [42][43][44][45] Fewer Americans perceive cannabis use as risky.…”

Section: Discussionmentioning

confidence: 99%

Prevalence of cannabis use has significantly increased in patients with cyclic vomiting syndrome

Siddiqui

Bilal

Singh

et al. 2020

Neurogastroenterology Motil

View full text Add to dashboard Cite

Introduction Cyclic vomiting syndrome (CVS) is a functional gastrointestinal disorder which leads to multiple hospitalizations and causes significant impairment of quality of life. Cannabis use is common in patients with CVS, and there are limited data on the national trends in the prevalence of its use in the United States. Methods We used the National Inpatient Sample (NIS) database from 2005 to 2014 and identified hospitalizations with a primary diagnosis of CVS by utilizing the International Classification of Diseases, 9th revision Clinical Modification (ICD‐9 CM) coding system. The primary objective of the study was to analyze the prevalence and trends in cannabis use in CVS patients. We also assessed healthcare resource utilization associated with cannabis use. Results A total of 129 090 hospitalizations with a primary diagnosis of CVS were identified and included in the study. In the United States, the overall rate of cannabis use among these patients was 104 per 1000 hospitalizations (N = 13 460). Over the last decade, the prevalence of cannabis use increased by 10‐fold, from 2.2% in 2005 to 21.2% in 2014. Conclusion Our analysis of the national database suggests that nearly 1 in 5 CVS hospitalizations have concurrent cannabis use. This prevalence is significantly rising over the last decade, perhaps due to changing legislation and increased utilization of cannabis. Age younger than 35, male gender, African American and Native American race, personal history of alcohol abuse and tobacco use were some of the strongest predictors of cannabis use.

show abstract

Section: Discussionmentioning

confidence: 99%

Prevalence of cannabis use has significantly increased in patients with cyclic vomiting syndrome

Siddiqui

Bilal

Singh

et al. 2020

Neurogastroenterology Motil

View full text Add to dashboard Cite

show abstract

“…For example, MC has been shown to be more common among males compared to females (Haug et al,2017). Furthermore, there may be higher levels of stigma associated with MC use (Leos-Toro et al, 2018).…”

Section: Introductionmentioning

confidence: 99%

Factors Influencing Demand for Medical Cannabis Use among Cancer Patients in the North of Thailand

Sukrueangkul

Panomai

Laohasiriwong

et al. 2022

Asian Pac J Cancer Prev

View full text Add to dashboard Cite

Objective: Cancer treatments often cause side effects. Cannabis is a plant that has been studied and used to treat and relieve side effects from modern medicine. Medical cannabis (MC) was legalized in Thailand in 2019 with limited research on demand for its use. Therefore, this study aimed to identify factors associated with demand for MC use among cancer patients in the North of Thailand. Methods: This analytical cross-sectional study administered a multistage random sampling to recruit 1,284 cancer patients in northern Thailand to response a self-administered structured questionnaire. Generalized Linear Mixed Model (GLMM) was used to identify the determinants of demand for MC use among the population, presented adjusted odds ratios (adj.OR), 95% confidence intervals (95% CI), and p-values. Result: Nearly half of the respondents reported demand to use MC (44.0%). The factors that were significantly associated with demand to use MC included had high levels of health literacy about MC (adj.OR = 5.70; 95% CI: 4.08 to 7.96), higher levels of social support (adj.OR =5.50; 95% CI: 3.60 to 8.39), positive attitudes toward MC use (adj.OR = 2.56; 95% CI: 1.83 to 3.56), aged less than 30 (adj.OR =1.89; 95% CI: 1.21 to 2.93), diagnosis with cancerfor more than 12 months ago (adj.OR =1.73; 95% CI: 1.19 to 2.52) when controlling effect of other covariates. Conclusion: We found substantial demand for MC use among cancer patients. Health literacy,social support, attitudes about MC, age, and duration of having cancer were significantly associated with demand for MC use. Therefore, improving health literacy and social support, especially among older cancer patients, could help increasing demand for MC as a complementary medicine to treat cancers.

show abstract

“…One such therapy recently garnering international attention is medicinal cannabis, currently legalized in Canada, 28 American states, the District of Columbia, Guam, and Puerto Rico [ 11 , 12 ]. Public acceptance of cannabinoids for both medical and recreational purposes is increasing, with a recent survey reporting that two-thirds of medical cannabinoid users felt supported by friends and family [ 13 ].…”

Section: Introductionmentioning

confidence: 99%

The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review

Nabata

Tse

Nightingale

et al. 2021

View full text Add to dashboard Cite

Background: People with spinal cord injuries (SCI) commonly experience pain and spasticity, but limitations of current treatments have generated interest in cannabis as a possible therapy. Objectives: We conducted this systematic review to: 1) examine usage patterns and reasons for cannabinoid use, and 2) determine the treatment efficacy and safety of cannabinoid use, in people with SCI. Methods: PubMed, Embase, Web of Science and Cumulative Index to Nursing and Allied Health Literature databases were queried for keywords related to SCI and cannabinoid. Results: 7,232 studies were screened, 34 were included in this systematic review. Though 26 studies addressed cannabinoid usage, only 8 investigated its therapeutic potential on outcomes such as pain and spasticity. The most common usage method was smoking. Relief of pain, spasticity and pleasure were the most common reasons for use. Statistically significant reduction of pain and spasticity was observed with cannabinoid use in 80% and 90% of experimental studies, respectively. However, on examination of randomized control trials (RCTs) alone, effect sizes ranged from -0.82 to 0.83 for pain and -0.95 to 0.09 for spasticity. Cannabinoid use was associated with fatigue and cognitive deficits. Conclusions: Current evidence suggests cannabinoids may reduce pain and spasticity in people with SCI, but its effect magnitude and clinical significance is unclear. Existing information is lacking on optimal dosage, method of use, composition and concentration of compounds. Longterm, double-blind, RCTs, assessing a wider range of outcomes should be conducted to further understanding of the effects of cannabinoid use in people with SCI.

show abstract

Perceived support for medical cannabis use among approved medical cannabis users in Canada

Cited by 31 publications

References 21 publications

Prevalence of cannabis use has significantly increased in patients with cyclic vomiting syndrome

Prevalence of cannabis use has significantly increased in patients with cyclic vomiting syndrome

Factors Influencing Demand for Medical Cannabis Use among Cancer Patients in the North of Thailand

The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review

Contact Info

Product

Resources

About